CBRE Group (CBRE) is up after a new bullish analyst adjustment hit the tape: Barclays raised its price target to $178 from $175 and kept an Overweight rating. With no new company filing announced today, the target increase is the most direct, time-stamped catalyst tied to the latest leg higher in the shares. (streetinsider.com)

The analyst action lands shortly after CBRE posted Q1 2026 results and lifted its full-year 2026 core EPS outlook to $7.60–$7.80 (up from $7.30–$7.60). That raised profit outlook is a key support for incremental price-target increases and helps frame the bid behind the stock on up days even when broader real-estate sentiment is mixed. (ir.cbre.com)

Traders will focus on whether additional firms follow with upgrades/target raises, and whether management commentary sustains expectations for accelerating transaction and services activity into mid-2026. The next catalyst that can amplify or fade today’s move is any follow-on estimate revisions tied to the higher 2026 earnings range and segment-level momentum discussed around the Q1 release. (cbre.com)